KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.89 $4.97 Friday, 26th Apr 2024 ALDX stock ended at $3.93. This is 0.254% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.79% from a day low at $3.83 to a day high of $3.98.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Dec 01, 2023 $2.82 $2.90 $2.69 $2.86 905 060
Nov 30, 2023 $2.77 $2.90 $2.77 $2.77 1 687 366
Nov 29, 2023 $2.69 $2.96 $2.69 $2.77 1 107 997
Nov 28, 2023 $2.52 $2.73 $2.47 $2.70 1 439 810
Nov 27, 2023 $2.50 $2.63 $2.43 $2.62 1 001 976
Nov 24, 2023 $2.59 $2.65 $2.51 $2.53 427 560
Nov 22, 2023 $2.45 $2.62 $2.45 $2.53 938 847
Nov 21, 2023 $2.69 $2.70 $2.44 $2.44 1 010 637
Nov 20, 2023 $2.80 $2.87 $2.63 $2.66 1 389 284
Nov 17, 2023 $2.50 $2.93 $2.48 $2.85 2 069 642
Nov 16, 2023 $2.57 $2.58 $2.43 $2.49 971 758
Nov 15, 2023 $2.55 $2.69 $2.51 $2.52 1 037 668
Nov 14, 2023 $2.46 $2.59 $2.46 $2.58 1 252 767
Nov 13, 2023 $2.31 $2.46 $2.23 $2.46 826 927
Nov 10, 2023 $2.37 $2.37 $2.20 $2.29 874 185
Nov 09, 2023 $2.58 $2.60 $2.32 $2.36 1 506 780
Nov 08, 2023 $2.67 $2.90 $2.52 $2.61 2 746 654
Nov 07, 2023 $2.28 $2.77 $2.26 $2.77 3 750 881
Nov 06, 2023 $2.22 $2.44 $2.20 $2.25 2 201 313
Nov 03, 2023 $2.11 $2.27 $2.07 $2.21 2 260 665
Nov 02, 2023 $2.50 $2.67 $2.06 $2.09 10 601 681
Nov 01, 2023 $2.00 $2.73 $1.97 $2.54 66 026 332
Oct 31, 2023 $1.53 $1.77 $1.53 $1.71 1 103 676
Oct 30, 2023 $1.47 $1.60 $1.47 $1.54 706 414
Oct 27, 2023 $1.59 $1.63 $1.46 $1.47 939 674
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT